ArticleThe Journal of clinical endocrinology and metabolism2026
Real-world effectiveness of burosumab across age groups: X-linked hypophosphatemia (XLH) Disease Monitoring Program.
Leanne M Ward et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.